Pangenomic Health Inc. NARA
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -72.57% | -141.81% | -3.48% | -783.23% | 84.56% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -93.33% | -95.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20,522.22% | 456.16% | 387.61% | 1,824.26% | -99.89% |
| Change in Net Operating Assets | -140.11% | -104.77% | -74.59% | -281.08% | 51.47% |
| Cash from Operations | -66.58% | -548.84% | -618.40% | -9,523.89% | -164.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 62.36% | 509.48% | -- | -- | 204.68% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -447.06% | -- | -252.94% |
| Cash from Financing | 42.29% | 536.89% | 9,991.67% | -- | 256.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -953.57% | 87.50% | -55.50% | 386.73% | 126.92% |